246 related articles for article (PubMed ID: 36361903)
1. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
2. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
3. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
4. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
Rast JP; D'Alessio S; Kraev I; Lange S
Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
7. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
8. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.
Méchin MC; Takahara H; Simon M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952341
[TBL] [Abstract][Full Text] [Related]
9. Insights into peptidylarginine deiminase expression and citrullination pathways.
Yu K; Proost P
Trends Cell Biol; 2022 Sep; 32(9):746-761. PubMed ID: 35197210
[TBL] [Abstract][Full Text] [Related]
10. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
Wang S; Wang Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminase and deiminated proteins are detected throughout early halibut ontogeny - Complement components C3 and C4 are post-translationally deiminated in halibut (Hippoglossus hippoglossus L.).
Magnadóttir B; Bragason BT; Bricknell IR; Bowden T; Nicholas AP; Hristova M; Guðmundsdóttir S; Dodds AW; Lange S
Dev Comp Immunol; 2019 Mar; 92():1-19. PubMed ID: 30395876
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.
Jang B; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
Prion; 2013; 7(1):42-6. PubMed ID: 23022892
[TBL] [Abstract][Full Text] [Related]
15. ROLE OF PEPTIDYLARGININE DEIMINASE AND NEUTROPHIL EXTRACELLULAR TRAPS IN INJURIES: FUTURE NOVEL DIAGNOSTICS AND THERAPEUTIC TARGETS.
Ho JW; Quan C; Gauger MA; Alam HB; Li Y
Shock; 2023 Feb; 59(2):247-255. PubMed ID: 36597759
[TBL] [Abstract][Full Text] [Related]
16. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
18. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
19. Putative Roles for Peptidylarginine Deiminases in COVID-19.
Arisan ED; Uysal-Onganer P; Lange S
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629995
[TBL] [Abstract][Full Text] [Related]
20. The Proteome and Citrullinome of
Magnadóttir B; Kraev I; Dodds AW; Lange S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
